1.
Weng J, Huang A, Berake TB, Chen SL, Yan BM, Karagozian R. Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterol Res. 2026;19(3):147-154. doi:10.14740/gr2136